Kamada (KMDA) Accumulated Expenses (2012 - 2026)
Kamada (KMDA) posted quarterly Accumulated Expenses of $24.9 million for Q1 2026, up 29.04% year-on-year from $19.3 million in Q1 2025, and up 105.9% on a QoQ basis from $12.1 million in Q4 2025.
Kamada (KMDA) Accumulated Expenses (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Accumulated Expenses for 15 consecutive years, with $24.9 million the latest figure, recorded in Q1 2026.
- Quarterly Accumulated Expenses rose 29.04% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (up 29.04% YoY) and the FY2025 annual result came in at $12.1 million, up 25.2% from the prior year.
- Accumulated Expenses advanced to $24.9 million in Q1 2026 per KMDA's latest filing, from $12.1 million in the prior quarter.
- Over the last five years, Accumulated Expenses for KMDA reached as high as $24.9 million in Q1 2026 and fell as low as $7350.0 in Q1 2023.
- A 5-year average of $8.8 million and a median of $7.6 million in 2022 frame the typical range for Accumulated Expenses.
- The largest YoY upside for Accumulated Expenses was 91973.48% in 2023 against a maximum downside of 99.89% in 2023.
- Year by year, Accumulated Expenses stood at $7.6 million in 2022, then climbed by 8.91% to $8.3 million in 2023, then increased by 17.07% to $9.7 million in 2024, then increased by 25.2% to $12.1 million in 2025, then soared by 105.9% to $24.9 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $24.9 million, $12.1 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.93 Mn |
| Dec 31, 2025 | 12.11 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | 8.80 Mn |
| Mar 31, 2025 | 19.32 Mn |
| Dec 31, 2024 | 9.67 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 6.21 Mn |
| Dec 31, 2023 | 8.26 Mn |
| Sep 30, 2023 | 7.32 Mn |
| Jun 30, 2023 | 7.24 Mn |
| Mar 31, 2023 | 7,350.00 |
| Dec 31, 2022 | 7.59 Mn |
| Sep 30, 2022 | 7,948.00 |
| Jun 30, 2022 | 6.11 Mn |
| Mar 31, 2022 | 6.67 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 6.35 Mn |
| Jun 30, 2021 | 6.99 Mn |